Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-124575
Filing Date
2024-11-12
Accepted
2024-11-12 07:30:35
Documents
50
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcrx-20240930.htm   iXBRL 10-Q 2072894
2 EX-31.1 tcrx-ex31_1.htm EX-31.1 21103
3 EX-31.2 tcrx-ex31_2.htm EX-31.2 21121
4 EX-32.1 tcrx-ex32_1.htm EX-32.1 8463
5 EX-32.2 tcrx-ex32_2.htm EX-32.2 9528
  Complete submission text file 0000950170-24-124575.txt   6069548

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tcrx-20240930.xsd EX-101.SCH 987642
53 EXTRACTED XBRL INSTANCE DOCUMENT tcrx-20240930_htm.xml XML 577195
Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40603 | Film No.: 241443307
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)